BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17484718)

  • 1. MIMS is not a stand-alone resource.
    Donohoo EA
    Med J Aust; 2007 May; 186(9):484. PubMed ID: 17484718
    [No Abstract]   [Full Text] [Related]  

  • 2. The National Prescribing Service should lead.
    Stockigt JR
    Med J Aust; 2007 May; 186(9):484. PubMed ID: 17484717
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicines and breastfeeding: information is available on safe use.
    Amir LH
    Med J Aust; 2007 May; 186(9):485. PubMed ID: 17484719
    [No Abstract]   [Full Text] [Related]  

  • 4. Product information past perfect.
    Dowden JS
    Med J Aust; 2007 Jan; 186(2):51-2. PubMed ID: 17223760
    [No Abstract]   [Full Text] [Related]  

  • 5. Barriers in the quest for quality drug information: salutary lessons from TGA-approved sources for thyroid-related medications.
    Stockigt JR
    Med J Aust; 2007 Jan; 186(2):76-9. PubMed ID: 17223768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specialist societies can assist.
    Bach LA
    Med J Aust; 2007 May; 186(9):483. PubMed ID: 17484714
    [No Abstract]   [Full Text] [Related]  

  • 7. Data sheets: a consumer perspective.
    Medawar C
    Lancet; 1988 Apr; 1(8588):777-8. PubMed ID: 2895311
    [No Abstract]   [Full Text] [Related]  

  • 8. Lessons from cisapride.
    CMAJ; 2001 May; 164(9):1269, 1271. PubMed ID: 11341130
    [No Abstract]   [Full Text] [Related]  

  • 9. Dosing information for paediatric patients: are they really "therapeutic orphans"?
    Caswell AJ
    Med J Aust; 2003 Nov; 179(10):560. PubMed ID: 14609429
    [No Abstract]   [Full Text] [Related]  

  • 10. Call in independent information sources.
    Dowden JS
    Med J Aust; 2007 May; 186(9):484. PubMed ID: 17484716
    [No Abstract]   [Full Text] [Related]  

  • 11. [Unclear on dose adjustment in renal impairment].
    Asker-Hagelberg C; Rydberg D; Hentschke M; Holm L; Rosenborg S; Elinder CG
    Lakartidningen; 2013 May 22-28; 110(21):1030-2. PubMed ID: 23805768
    [No Abstract]   [Full Text] [Related]  

  • 12. Dosing information for paediatric patients: are they really "therapeutic orphans"?
    Tan E; Cranswick NE; Rayner CR; Chapman CB
    Med J Aust; 2003 Aug; 179(4):195-8. PubMed ID: 12914509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiencies in drug interaction information.
    Sweidan M; Reeve JF
    Med J Aust; 2007 May; 186(9):483. PubMed ID: 17484715
    [No Abstract]   [Full Text] [Related]  

  • 14. Keeping up with drug use and safety.
    Long CO
    Home Healthc Nurse; 2004 Aug; 22(8):530-1. PubMed ID: 15314556
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of medicines information for patient safety.
    Pappa D; Telonis P; Stergioulas LK
    J Telemed Telecare; 2006; 12 Suppl 1():34-6. PubMed ID: 16884574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information or advertising?
    Coulter A
    Health Expect; 2001 Dec; 4(4):203-4. PubMed ID: 11703492
    [No Abstract]   [Full Text] [Related]  

  • 17. Rules set for dissemination of off-label-use information.
    Miller JL
    Am J Health Syst Pharm; 1999 Feb; 56(3):204. PubMed ID: 10030500
    [No Abstract]   [Full Text] [Related]  

  • 18. What drug labels don't tell you.
    Consum Rep; 2011 Aug; 76(8):10. PubMed ID: 21770080
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 20. Stoning a dead bird: advertising limits on approved new drugs.
    Strobos J
    Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.